Business Wire

21st BraunPrize Seeks to Reward Good Design That Will Shape Tomorrow

Share

Braun celebrates its 100th anniversary in 2021 and we are pleased to announce the 21st BraunPrize International Design Competition, with a virtual awards ceremony due to take place in October 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210511005118/en/

Established in 1968, the BraunPrize was Germany’s first international competition with the aim to promote the work of young designers. Braun’s continuous commitment to this cause has been highly regarded by the design world and the design-aware public ever since.

This year, young, up-and-coming designers and inventors will be tasked with exploring good design to address and solve the challenges of today and tomorrow; and Braun’s commitment to nurturing young talent will see this year’s total prize value increase to $100,000 USD.

A recent global study, conducted by Braun of 18-25 year olds, revealed that Gen Z believes that good design will play a pivotal role in its future. In fact, 4 out of 5 (78%) agreed that accessibility—regardless of age, impairments or skill level—and ease of use are the single most important areas in which design can deliver an impactful change. Simple and useful design means good design for everyone—design that anyone can understand and anyone can make use of to better their life and to better our collective future.

Braun has shaped the past, present and future with ‘good design’. Braun believes that good design follows the principles of ‘Simple, Useful and Built to last,’ and that these design tenents remain as relevant in 2021 as they were in 1921 in making life better for people and the environment. Braun knows that the next 100 years will be shaped through the power of ‘good design’ for our collective benefit, so the 2021 BraunPrize International Design Competition will challenge creative minds to help shape tomorrow.

Oliver Grabes, Head of Braun Design and Chairman of the BraunPrize commented:

“The 2021 BraunPrize International Design Competition challenge is an opportunity for young designers, inventors and students to identify design ideas and visionary concepts that will help promote behavioral change and make an impact on today’s society and the future of our planet. Design that can effect this type of positive social impact is good design at its best.

Oliver continued: “We are really excited by this year’s competition and encourage you to help us shape tomorrow. 2018 saw more submissions than ever, with 3,087 entrants from 107 counties, making it a record year for the BraunPrize. We can’t wait to see what the 2021 BraunPrize International Design Competiton will unearth.”

For more information, please visit www.uk.braun.com/en-gb/braunprize or on Instagram @braunprize.

THE 2021 BRAUN PRIZE INTERNATIONAL DESIGN COMPETITION DETAILS

THE 2021 CHALLENGE: SHAPE TOMORROW

A call to action to help shape tomorrow. A forum for young designers, inventors and students with a commitment to exploring good design to address and solve the challenges of today and tomorrow.

WHO IS ELIGIBLE

The 2021 BraunPrize International Design Competition is open globally and is free to enter. Submissions are welcome from young designers and inventors with less than 5 years work experience and students of any profession.

PRIZE MONEY

The BraunPrize International Design Competition will award $100,000 USD in prize money.

JURY PANEL

The 2021 BraunPrize Internation Design Competition Jury Panel will comprise of international design leaders from across the globe.

SUBMISSION

Submissions for the 2021 BraunPrize International Design Competition will open in July 2021 and the BraunPrize Winner announcements will take place in October 2021.

NOTES TO EDITORS

  • The BraunPrize was established in 1968
  • The BraunPrize 2021 marks the 21st edition of the international design competition
  • In 2018, the BraunPrize received 3,087 entries from 107 countries
  • The BraunPrize 2021 is organized by Braun, a Procter & Gamble brand, and managed by the Braun Design Team in Kronberg, Germany
  • Braun, a subsidiary of Procter & Gamble founded in Germany in 1921, develops and manufactures a wide variety of small domestic appliances that marry technical innovation, reliable quality and distinctive design. These range from electric shavers and beauty products to hair care appliances. Braun products enjoy worldwide distribution. Please visit www.braun.com for the latest news and in-depth information about the Braun brand.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

LEANDRA CARDOZO
leandra.cardozo@saatchi.co.uk

LAURA THOMAS
laura.thomas@saatchi.co.uk

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

deWiz Making a Buzz After Closing out Series-A Funding With More Than 5 Million USD Investment21.6.2021 15:33:00 CEST | Press release

After more than five years of development, deWiz’s new wearable technology is going to market after closing out its Series-A funding round with more than 5M USD in new investment. The funding will fuel deWiz’s go-to-market launch strategy with a robust marketing plan, staffing to support growth and resources to ensure a healthy supply chain. Additionally, investment was synced with a new composition of the board of directors for deWiz, including Chairman of the Board, CEO and co-founder Christian Bergh; CTO and co-founder Markus Westerberg; World Golf Hall of Fame and business entrepreneur Annika Sörenstam; Newton Aguiar; and Erik Näsström. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210621005497/en/ deWiz wearable tech, a new golf training aid that helps golfers swing, feel and improve more quickly by providing instantaneous feedback via an electric pulse. (Photo: Business Wire) The science behind deWiz minimizes the gue

Membership Collective Group Announces Filing of Registration Statement for Proposed Initial Public Offering21.6.2021 15:32:00 CEST | Press release

Membership Collective Group (“MCG”), a global membership platform comprised of Soho House, Soho Works, The Ned, Scorpios Beach Club and Soho Home, and related digital platforms, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. MCG has applied to list its Class A common stock on the New York Stock Exchange under the ticker symbol “MCG”. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210621005494/en/ Soho House New York (Graphic: Business Wire) J.P. Morgan and Morgan Stanley will serve as joint lead book runners for the proposed offering. Goldman Sachs & Co. LLC, BofA Securities and HSBC will be joint book runners. Citibank will serve as a co-manager. The

American Express Plans Live Audio Webcast of Second Quarter 2021 Earnings Conference Call21.6.2021 15:30:00 CEST | Press release

American Express Company (NYSE: AXP) plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Friday, July 23, 2021, to discuss second quarter 2021 financial results. The webcast will be accessible to the general public through the American Express Investor Relations website at https://ir.americanexpress.com/. The financial results and presentation materials are scheduled to be released and posted on the website at approximately 7 a.m. (ET) prior to the conference call, and an audio replay will be available on the website following the call. ABOUT AMERICAN EXPRESS American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress, instagram.com/americanexpress, linkedin.com/company/american-express, twitter.com/americanexpress, and youtube.com/americanexpress. Vie

The Blood Center of New Orleans Cooperates With Biolog-id to Enhance Visibility, Availability, and Traceability of Life-saving Blood Components21.6.2021 15:17:00 CEST | Press release

Biolog-id LLC, a developer and service provider of connected healthcare solutions, announced today its partnership with The Blood Center of New Orleans. Biolog-id’s cutting-edge technology will provide digital visibility to all platelet types in accordance with the new FDA bacterial risk control guidance. The biolog-id solution will support operational, distribution and planning decisions across the entire lifecycle of these strategically important products. The use of the biolog-id solution for the rare red blood cells inventory will streamline the management of this complex inventory, facilitating better internal cooperation and optimizing the fulfilment of customer orders. “We are firm believers in leveraging technology to improve the efficiency, quality, and safety of the blood supply,” said Billy Weales, President & CEO at The Blood Center. “Our cooperation with biolog-id allows us to achieve these goals with two of our most critical blood components – platelets and rare red blood

Sky Labs Finalizes Series B Round Successfully Planning to Take Over Global Markets21.6.2021 15:00:00 CEST | Press release

Attracting USD 20 million investment, Sky Labs (CEO: Jack Lee), a global health care start-up, finalized Series B Round successfully. The accumulated amount of investment Sky Labs has attracted is USD 30 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210621005004/en/ Sky Labs, a global health care start-up, finalizes Series B Round successfully attracting USD 20 million investment. The accumulated amount of investment is USD 30 million. Sky Labs developed CART-I, the world’s first AI-based ring-type heart monitoring platform. It consists of a ring-type wearable medical device and user’s application and medical professional’s web platform and enables atrial fibrillation patients to conduct monitoring when they are not in a hospital. In addition, the photoplethysmography (PPG) sensor in the ring monitors the bloodstream in the finger to measure irregular pulse waves. The measured data are transmitted to a cloud platfo

Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of Migraine21.6.2021 14:01:00 CEST | Press release

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today presented new epidemiology data on migraine from the State of Israel which indicate that socio-economic factors may contribute to underdiagnosis of migraine across society1. A retrospective study of migraine epidemiology in Southern Israel, supported by Teva and presented at the virtual 7th Congress of the European Academy of Neurology (EAN), found extreme variability in the prevalence of diagnosed patients with migraine across the geographic area studied. Prevalence rates were positively associated with the socio-economic status of the geographic area studied, suggesting that those living with migraine from less advantaged areas may find it harder to achieve an accurate diagnosis and thereby access appropriate therapy. “These findings are concerning not least because they suggest significant ‘migraine awareness inequity’ in this population,” said Professor Gal Ifergane, study investigator, practitioner, head of the Depart

New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Academy of Neurology Congress21.6.2021 14:01:00 CEST | Press release

A new analysis presented by Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) on AJOVY® (fremanezumab) injection for the preventive treatment of migraine, indicates to the European neurology community that the medicine has a positive safety profile in relation to risk of cardiovascular events. The data, drawn from an analysis of three published Phase 3 studies of fremanezumab and presented at the 7th Congress of the European Academy of Neurology (EAN), showed minimal changes in the heart rate and blood pressure of those patients studied over a 12 week period. 1 “As a CGRP inhibitor, fremanezumab has been shown to provide protection against migraine in suitable patients, and we remain focused on continued assessment of the safety profile of this therapy, particularly in relation to heart-related issues as it is believed CGRP itself acts as a ‘safeguard’ during cardiovascular ischemia and other events,” said Dr Joshua M. Cohen, Senior Director and Global Therapeutic Area Lead, Mi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom